Search Results 1281-1290 of 20128 for Hepatitis C

1. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

   Evidence of active and uncontrolled hepatitis B and/or hepatitis C. Screening for hepatitis B and hepatitis C is not required. Participants previously ...

2. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

   Positive hepatitis B (hepatitis B surface antigen and antibody) and/or hepatitis C (hepatitis C antibody test) as indicated by serologies conducted =< 3 ...

3. Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission - Mayo Clinic

   No known Hepatitis B, Hepatitis C active disease. No known Human Immunodeficiency Virus (HIV) seropositivity. The risk for potential toxicities secondary to ...

4. Publications - Kevin O. Leslie, M.D. - Mayo Clinic

   Helmers RA, Byrne TJ, Wesselius LJ, Leslie KO. Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient. Mayo ...

5. A Study To Assess Efficacy And Safety Of Pembrolizumab With Or Without Sacituzumab Tirumotecan (MK- 2870) In Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) - Mayo Clinic

   * Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis ... C virus (defined as anti-HCV antibody ...

6. A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma - Mayo Clinic

   Known to be seropositive for hepatitis C (except in the setting of a sustained virologic response [SVR], defined as aviremia at least 12 weeks after completion ...

7. Liver biopsy - Doctors & Departments - Mayo Clinic

   There are no doctors whose last name begins with the letter C C ... 14, 2024. Related. Acute liver failure · Alcoholic hepatitis (Alcohol-associated hepatitis) ...

8. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

   Positive hepatitis C virus (HCV) antibody test result, unless the patient: ... In the screening hepatitis B assessment (which consists of testing for hepatitis ...

9. Mayo researchers invented a new class of AI to improve cancer research and treatments - Mayo Clinic News Network

   Mayo Clinic Minute: What is hepatitis C? Related Articles. Mayo Clinic uses DNA screening to prevent life-threatening reactions during anesthesia (VIDEO).

10. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    Participation eligibility · Documentation of HBsAg, hepatitis B surface antibody (HBsAb), hepatitis B core antibody (HBcAb), and hepatitis C virus (HCV) antibody ...